The Epidermal Growth Factor Receptor(EGFR), a transmembrane glycoprotein, is mutated in approximately 10–15%of European patients, more frequently in women, adenocarcinoma type and never-smokers[2]. Here, EGFR is linked to adenocarcinoma.